Skip to main content

Table 2 Thrombogenic risk

From: Infusion-related thrombogenesis by liver-derived mesenchymal stem cells controlled by anticoagulant drugs in 11 patients with liver-based metabolic disorders

 

Total patients

% of the total population

12.5 × 106/kg

50 × 106/kg

200 × 106/kg

Complication related to anticoagulation

4

36

   

 Hemorrhage at catheter

1

9

1

 Epistaxis

2

18

1

1

 Petechiae

1

9

1

Procoagulant events

1

9

   

 Portal thrombi

1

9

1

Prematurely stopped infusion cycles

4

36

   

 Catheter problems

2

18

2

 Transfusional reaction

1

9

 

1

 High D-dimer levels

1

9

  

1